Atara beats estimates with loss in Q1
Banking & Finance, Earnings, East Ventura County, Health Care & Life Science, Latest news, Tri-County Economy, Tri-County Public CompaniesAtara Biotherapeutics had a net loss of $78.2 million in the first quarter of fiscal year 2021, slightly higher compared than same quarter a year earlier, when the company had a loss of $73.5 million. Despite this, Atara, an immunotherapy biotech company based in South San Francisco with some of its major operations in Thousand Read More →
Thousand Oaks biotech firm closes $140M funding round
East Ventura County, Health Care & Life Science, Latest news, Startups, Technology, Tri-County EconomyCapsida Biotherapeutics, a biotechnology startup based in Thousand Oaks, announced April 29 that it is emerging from “stealth mode” with a $140 million funding round led by Westlake Village BioPartners and Versant Ventures. The Series A round includes $50 million from Westlake Village BioPartners, a venture capital firm in Thousand Oaks focused on biotech startups Read More →
Cal Poly to get $5M in federal funds for drone project
Central Coast, Higher Education, Latest news, Technology, Tri-County EconomyCal Poly San Luis Obispo will get $5 million in federal funds to form a partnership with the Air Force Research Laboratory to study drone technology. U.S. Rep. Salud Carbajal, D-Santa Barbara, was one of three reps who helped direct $10 million to Cal Poly SLO and Cal Poly Pomona in the Consolidated Appropriations Act Read More →
Teledyne shares up on earnings news as Flir acquisition draws nearer
Banking & Finance, Earnings, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public CompaniesTeledyne Technologies saw growth in nearly all markets during the first quarter of 2021, helping the company beat expectations and deliver positive results on its first earnings report of the year. Teledyne, a Thousand Oaks-based industrial and scientific conglomerate, reported an adjusted earnings per share of $3.02 for the first quarter of 2021, beating Zacks’ Read More →